Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh Watson

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
The Journal of Rheumatology|July 3, 2019
Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting SymptomsSarah R Tritsch, Liliana Encinales, Nelly Pacheco, et al.
Hepatology Communications|December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated CirrhosisElisa Pose, Elsa Solà, Juan J Lozano, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
The Journal of Rheumatology|July 3, 2019
Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting SymptomsSarah R Tritsch, Liliana Encinales, Nelly Pacheco, et al.
Hepatology Communications|December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated CirrhosisElisa Pose, Elsa Solà, Juan J Lozano, et al.
Gut|October 26, 2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysisAdrià Juanola, Ann Thu Ma, Koos de Wit, et al.
JAMA|February 5, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical TrialElisa Pose, César Jiménez, Giacomo Zaccherini, et al.
Pageof 6